Bacterial And Viral Specimen Collection Industry Outlook 2025-2029: Market Set to Cross $39.68 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Bacterial And Viral Specimen Collection Market Size By 2025?
In recent times, the market size for bacterial and viral specimen collection has seen a swift expansion. It is anticipated to escalate from $20.95 billion in 2024 to $23.86 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.9%. The surge during the historic phase could be linked to an increase in the need for precise and early detection, a rise in occurrences of viral outbreaks, more government funding, a hike in worldwide healthcare spending, and the expansion of telemedicine.

How Big Is the Bacterial And Viral Specimen Collection Market Size Expected to Grow by 2029?
The market size for bacterial and viral specimen collection is projected to experience a significant increase in the coming years, with an estimated compound annual growth rate (CAGR) of 13.6%, reaching $39.68 billion by 2029. The expected growth during the forecast period is widely attributed to the expansion of global disease surveillance networks, increased funding for pandemic readiness, a rising number of infectious diseases, increasing antibiotic resistance, and escalated bacterial infections. Meanwhile, the forecast period will also witness major trends such as technological advancements, digital tracking integration, the use of non-invasive specimen collection methods, the implementation of microfluidic devices, and the uptake of automated specimen tracking systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bacterial-and-viral-specimen-collection-global-market-report

Which Key Market Drivers Powering Bacterial And Viral Specimen Collection Market Expansion and Growth?
The escalating occurrence of infectious diseases is set to fuel the expansion of the bacterial and viral specimen collection market. These types of diseases are triggered by harmful microorganisms like bacteria, viruses, fungi, or parasites, and can be disseminated from one person to another, either directly or indirectly. The growth of infectious diseases is largely driven by urbanization, resulting in greater population density and closer human interaction, which speeds up disease transmission and provides optimal conditions for pathogens to spread across populations. The collection of bacterial and viral specimens is vital in managing infectious diseases, as it delivers critical samples needed for accurate detection and diagnosis, enabling timely and appropriate medical response. For example, as reported by the Centers for Disease Control and Prevention, a government agency in the United States, the number of tuberculosis cases surged from 8,320 in 2022 to 9,615 in 2023, a rise of 1,295 cases. Simultaneously, the incidence rate incremented from 2.5 to 2.9 per 100,000 individuals, showing a significant climb over the year. Hence, the escalating occurrence of infectious diseases is boosting the growth of the bacterial and viral specimen collection market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27219&type=smp

What Are the Key Trends Driving Bacterial And Viral Specimen Collection Market Growth?
Top corporations in the bacterial and viral specimen collection industry are committed to developing new solutions like viral DNA and RNA extraction kits, aimed at enhancing the effectiveness, precision, and speed of diagnosing and analysing pathogens. Viral DNA and RNA extraction kits are lab instruments used to separate and purify viral genetic material from clinical specimens for accurate molecular testing and diagnosis. For example, in April 2024, New England Biolabs, a life sciences firm based in the US, rolled out the Monarch Mag Viral DNA and RNA Extraction Kit. This magnetic bead-based purification kit is developed for quick, dependable, and highly sensitive extraction of viral DNA and RNA from various samples like saliva, respiratory swabs, and enriched wastewater. This kit supports manual as well as automated workflows suitable for platforms like KingFisher Flex and Agilent Bravo, facilitating high-capacity processing. The kit boosts detection sensitivity for low viral volumes, incorporates carrier RNA for better recovery, and is appropriate for downstream applications such as qPCR, RT-qPCR, ddPCR, and next-generation sequencing (NGS). The kit aims to fulfil requirements in infectious disease testing, viral genome sequencing, and environmental monitoring through scalable, hand-off workflows.

What Are the Emerging Segments in the Bacterial And Viral Specimen Collection Market?
The bacterial and viral specimen collection market covered in this report is segmented

1) By Product: Bacterial Specimen Collection, Viral Specimen Collection
2) By Application: Diagnostics, Research
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End User

Subsegments:
1) By Bacterial Specimen Collection: Swabs, Transport Media, Culture Plates & Media, Blood Culture Bottles, Biopsy And Tissue Collection Kits, Urine Collection Containers, Other Specialized Collection Devices
2) By Viral Specimen Collection: Viral Transport Media, Blood Collection Tubes, Saliva Collection Kits, Sputum Collection Containers, Stool Collection Kits, Other Specialized Collection Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27219&type=smp

Who Are the Global Leaders in the Bacterial And Viral Specimen Collection Market?
Major companies operating in the bacterial and viral specimen collection market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Becton inson and Company, Lonza Group AG, Hologic Inc., bioMérieux SA, Quidel Corporation, QIAGEN N.V., DiaSorin S.p.A., Greiner Bio-One International GmbH, Spectrum Solutions LLC, Hardy Diagnostics Inc., EKF Diagnostics Holdings Plc, Trinity Biotech Plc, Puritan Medical Products Company LLC, Wuxi NEST Biotechnology Co. Ltd., Copan Diagnostics Inc., VIRCELL S.L., Medical Wire & Equipment Co. Ltd., HiMedia Laboratories Pvt. Ltd., Longhorn Vaccines and Diagnostics LLC, and Beaver Biomedical Engineering Co. Ltd.

Which are the Top Profitable Regional Markets for the Bacterial And Viral Specimen Collection Industry?
North America was the largest region in the bacterial and viral specimen collection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bacterial and viral specimen collection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27219

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.